Pharmaceuticals

The Israeli startup using spatial biology to provide better cancer treatment

02.01.22 | Yafit Ovadia

CytoReason enters Japanese market with SPI partnership

30.09.21 | James Spiro

Israel’s RedHill Biopharma testing oral pill that cures Covid-19 symptoms

28.02.21 | Yafit Ovadia

Due to high demand for biotech, Pontifax crosses $1.3 billion funding threshold

12.10.20 | Tzally Greenberg

What’s behind the timed resurgence of lawsuits against Teva?

28.08.20 | Sophie Shulman

Hitting the Reset Button on Antibiotics

17.04.20 | Viki Auslender

Pharmaceutical Company AstraZeneca Launches Digital Health Program in Israel

27.11.19 | Meir Orbach

Teva Quarterly Report Meets Analyst Expectations

07.11.19 | Sophie Shulman

Teva Overcomes One Hurdle, Many Still Ahead

23.10.19 | Hezi Sternlicht

Teva to Close Missouri Plant, Report Says

29.08.19 | Tzally Greenberg

Rivals' Earning Reports Should Have Teva's Shareholders Worried

05.08.19 | Uri Tal-Tene

Teva to Pay California $69 Million in Narcolepsy Drug Settlement

30.07.19 | Hezi Sternlicht

Paving the Way to Alzheimer’s Cure, One Algorithm at a Time

19.07.19 | Tzipi Smilovitz

Pi Therapeutics Raises $19.7 Million

29.05.19 | Hagar Ravet

Derivative Suit Sheds Light on Teva’s Disastrous Rimsa Acquisition

28.05.19 | Hezi Sternlicht

Legal Troubles Could Weigh Down Teva’s Ability to Carry its Debt Covenants

16.05.19 | Uri Tal-Tenne

Teva’s Shady Legal Past Still Weighs on the Debt-Laden Pharma Company

12.05.19 | Hezi Sternlicht

Teva Completes $47.5 Million Sale of Northern Israeli Plant to Private Equity Fund FIMI

02.05.19 | Hezi Sternlicht

Can-Fite BioPharma Receives $1 Million From CKD Pharmaceuticals as Part of Expanded Agreement

16.04.19 | CTech

Can-Fite BioPharma to Raise $3.2 Million in Direct Offering

04.04.19 | CTech

Teva Makes Headway in European Copaxone Patent Case

01.04.19 | Lilach Baumer

Life Science Investment Firm Pontifax Raises $170 Million Fund

22.11.18 | Meir Orbach

Biotech Company Polypid Raises $15 Million

07.11.18 | Lilach Baumer

Former Teva Executives Raise $60 Million for Metabolic Disorders Venture

28.10.18 | Lilach Baumer

China’s CMS Medical Signs Multi-Million Dollar Deal With Israeli Pharma Company Can-Fite

07.08.18 | Amarelle Wenkert

Teva Trending Down Following Underwhelming Second Quarter Revenues

02.08.18 | Dror Reich

Mylan Cuts Price of Generic Copaxone Offering by 60%

11.07.18 | Lilach Baumer

Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering

10.07.18 | CTech

Teva to Relocate U.S. Headquarters to New Jersey

08.07.18 | Lilach Baumer

Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight

05.07.18 | CTech